Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Azab Mohammad, Director. Insider active across 4 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 11 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 December 2021. The latest transaction was disclosed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Mohammad Azab is a Director at Xenon Pharmaceuticals Inc. and Durect Corp, companies specializing in the biopharmaceutical sector. In this role, he participates in the governance of these companies and strategic decision-making. His experience in the sector allows him to provide valuable insights into growth opportunities and market challenges.